Plain-English translation of NCT06595719 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Ulcerative Colitis research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a multi-strain probiotic supplement โ a combination of beneficial bacteria from the Bifidobacterium and Lactobacillus families โ added to your regular ulcerative colitis care. The study will compare people who receive the medication with those who receive a placebo (inactive pill) over 12 weeks. Researchers want to see if this treatment can help restore the balance of bacteria in your gut, strengthen your intestinal lining, and reduce inflammation.
Many people with mild to moderate ulcerative colitis continue to have symptoms or side effects even with current treatments. Recent research suggests that an imbalance in gut bacteria plays a role in ulcerative colitis, so this study is exploring whether restoring that balance with this medication might help patients feel better and achieve longer-lasting improvement.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will take either the probiotic supplement or a placebo pill daily for 12 weeks, while continuing your regular ulcerative colitis medications at the same dose. You will need to keep taking your standard medications unchanged throughout the study and avoid certain other medications like NSAIDs and antibiotics during this time. The study will likely include visits where your symptoms are checked, and possibly tests or procedures to measure how well your intestines are healing.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
Malaysia